−3.44EUR
−147.74 MEUR
45.89 M
About ABIVAX
Sector
CEO
Marc M. P. de Garidel
Headquarters
Paris
Website
Employees (FY)
61
Founded
2013
ISIN
FR0012333284
FIGI
BBG009CG7F64
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ABVX is 15.18 EUR — it has increased by 5.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange ABIVAX stocks are traded under the ticker ABVX.
ABIVAX is going to release the next earnings report on Sep 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ABVX stock is 5.63% volatile and has beta coefficient of 1.27. Check out the list of the most volatile stocks — is ABIVAX there?
Yes, you can track ABIVAX financials in yearly and quarterly reports right on TradingView.
ABVX stock has risen by 10.80% compared to the previous week, the month change is a 10.96% rise, over the last year ABIVAX has showed a 1.07% increase.
ABVX net income for the last quarter is −95.79 M EUR, while the quarter before that showed −51.95 M EUR of net income which accounts for −84.37% change. Track more ABIVAX financial stats to get the full picture.
Today ABIVAX has the market capitalization of 906.01 M, it has decreased by 4.13% over the last week.
No, ABVX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ABVX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABIVAX stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 61.00 employees. See our rating of the largest employees — is ABIVAX on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABIVAX technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABIVAX stock shows the buy signal. See more of ABIVAX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ABIVAX future price: according to them, ABVX price has a max estimate of 65.00 EUR and a min estimate of 14.95 EUR. Read a more detailed ABIVAX forecast: see what analysts think of ABIVAX and suggest that you do with its stocks.